Health1 year ago
Ozempic And Wegovy Prices Face Scrutiny From Novo Nordisk, Blames US Health System
Novo Nordisk A/S (NYSE: NVO) has reported that it retains about sixty percent of the list price of Ozempic and Wegovy, its medications for diabetes and...
